KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 180 filers reported holding KARUNA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $46,292,487 | +3.9% | 213,477 | -13.0% | 0.06% | -1.8% |
| Q1 2023 | $44,558,835 | +98370.4% | 245,314 | +6.5% | 0.06% | -13.8% |
| Q4 2022 | $45,251 | -99.8% | 230,284 | +85.5% | 0.06% | +58.5% |
| Q3 2022 | $27,928,000 | +84.4% | 124,161 | +3.7% | 0.04% | +95.2% |
| Q2 2022 | $15,147,000 | -0.6% | 119,731 | -0.4% | 0.02% | +23.5% |
| Q1 2022 | $15,246,000 | -40.6% | 120,245 | -38.6% | 0.02% | -34.6% |
| Q4 2021 | $25,654,000 | -39.3% | 195,830 | -43.3% | 0.03% | -44.7% |
| Q3 2021 | $42,249,000 | – | 345,371 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |